Pediatrics

Digital Education Hubs

Cardiometabolic health begins in childhood. Experts agree that it’s much easier to prevent the gamut of cardiovascular disease, obesity, insulin resistance, and related conditions than to treat them once they exist. Including pediatric subjects in medical research provides early clues as to what behaviors, genetics, environments, and other key factors contribute to cardiometabolic health adulthood.

News Digest

The latest industry news, CMHC Pulse Blogs and Cardiometabolic Chronicle articles related to pediatric cardiometabolic health.

FDA Extends Approval for Alirocumab to Lower LDL-C in Pediatric Patients with HeFH 

Identifying and Treating Severe Hypoglycemia in Pediatric Patients with Diabetes

Prevention and Treatment of Pediatric Obesity: Utilizing the Spectrum of Available Tools to Optimize Treatment

Rising Cancer Incidence in Adolescents and Young Adults 

Myocarditis Rates Up in Vaccinated Male Adolescents

Heart Health Month: Cardiac Dysfunction in Children with COVID-19

The Impact of Obesity on Pediatric COVID-19 Illness

Diabulimia: The World’s Most Dangerous Eating Disorder Tied to T1D

Maternal A1c Linked to Autism Risk in Children

Expert Highlights and Perspectives

A cache of recorded faculty presentations addressing the diagnosis, clinical management, treatment, and emerging strategies related to pediatric cardiometabolic health.

Expert Highlights & Perspectives from CMHC Pediatric Masterclass 2022 developed in collaboration with the Florida Chapter of the American Academy of Pediatrics (FCAAP)

The Big Picture of Cardiometabolic Risk in the Pediatric Population - Jessica G. Woo, MHSA, PhD

Jessica G. Woo, MHSA, PhD

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Prevention of Pediatric Obesity - Carissa M. Baker-Smith, MD, MPH

Carissa  Baker-Smith MD, MS
Carissa Baker-Smith MD

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Food Availability & Obesogenic Environments as Contributors to Overweight and Obesity in Children - Jessica G. Woo, MHSA, PhD

Jessica G. Woo, MHSA, PhD

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Tackling Pediatric Obesity: Utilizing the Spectrum of Available Tools to Optimize Treatment - Aaron S. Kelly, Ph.D

Aaron S. Kelly, Ph.D
Aaron S. Kelly, Ph.D

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Panel Discussion, Audience Q & A: Lifestyle Interventions to Tackle Cardiometabolic Risk in Children and Adolescents

Jessica G. Woo  MHSA, PhD
Jessica G. Woo, MHSA, PhD
Carissa  Baker-Smith MD, MS
Carissa Baker-Smith MD
Aaron S. Kelly, Ph.D
Aaron Kelly, PhD
Elaine M. Urbina, MD, MS
Elaine M. Urbina, MD, MS

Panelists: Jessica G. Woo, MHSA, PhD; Carissa Baker-Smith MD; Aaron Kelly, PhD; Elaine M. Urbina, MD, MS

Hypertension in Children & Adolescents - Shani H.Cunningham, DO, M.Ed, FAAP Pediatric Dyslipidemia

Shani Cunningham
Shani H. Cunningham, DO, M.Ed, FAAP

Type 2 Diabetes in Children and Adolescents: Screening, Diagnosis, and Management - Jay Shubrook, DO

Jay Shubrook, DO

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Pediatric Non-Alcoholic Fatty Liver Disease: Assessment and Management - Stavra Xanthakos, MD, MS

Stavra Xanthakos, MD, MS

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Target Organ Damage Related to Cardiometabolic Disease - Stephen R. Daniels, MD, PhD

Stephen R. Daniels, MD, PhD

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Use of Technology for Managing Obesity & Cardiometabolic Risk: Challenges, Advances & Perspectives - Eden M. Miller DO, FBOM

Eden M. Miller, DO
Eden M. Miller DO, FBOM

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Panel Discussion, Audience Q & A: Comprehensive Treatment of Cardiometabolic Risk in the Pediatric Population

Elaine M. Urbina, MD, MS
Elaine M. Urbina, MD, MS
Stavra Xanthakos, MD, MS
Jay Shubrook, DO
Stephen R. Daniels, MD, PhD
Shani Cunningham
Shani H. Cunningham, DO, M.Ed, FAAP

Moderator: Elaine M. Urbina, MD, MS

Panelists: Stephen R. Daniels, MD, PhD; Stavra Xanthakos, MD, MS; Jay Shubrook, DO; Amy L. Peterson, MD; Eden M. Miller DO, FBOM; Shani H.Cunningham, DO, M.Ed, FAAP

Resources

A collection of resources related to pediatric cardiometabolic health for both patients and provider education and connection.

Quick Links
Additional Resources

Collection of Slides from CMHC Masterclass: “Addressing Cardiometabolic Risk in Children and Adolescents: Challenges and Solutions”, held live on September 2022 in collaboration with the Florida Chapter of the American Academy of Pediatrics (FCAAP)

Drug Pipeline

Key emerging drugs for the management of select and relevant pediatric cardiometabolic health conditions that are being studied in various stages of clinical trials, or that were recently approved by the U.S. Food and Drug Administration for therapeutic use.

HeFH = heterozygous familial hypercholesterolemia; HoFH = homozygous familial hypercholesterolemia; PCSK9 = Proprotein convertase subtilisin/kexin type 9

Coming Soon

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.